Brain volumetric deficits in MAPT mutation carriers: a multisite study

被引:22
|
作者
Chu, Stephanie A. [1 ]
Flagan, Taru M. [1 ]
Staffaroni, Adam M. [1 ]
Jiskoot, Lize C. [2 ,3 ]
Deng, Jersey [1 ]
Spina, Salvatore [1 ]
Zhang, Liwen [1 ]
Sturm, Virginia E. [1 ]
Yokoyama, Jennifer S. [1 ]
Seeley, William W. [1 ]
Papma, Janne M. [2 ]
Geschwind, Dan H. [4 ]
Rosen, Howard J. [1 ]
Boeve, Bradley F. [5 ]
Boxer, Adam L. [1 ]
Heuer, Hilary W. [1 ]
Forsberg, Leah K. [5 ]
Brushaber, Danielle E. [5 ]
Grossman, Murray [6 ]
Coppola, Giovanni [4 ]
Dickerson, Bradford C. [7 ]
Bordelon, Yvette M. [4 ]
Faber, Kelley [8 ]
Feldman, Howard H. [9 ]
Fields, Julie A. [5 ]
Fong, Jamie C. [1 ]
Foroud, Tatiana [8 ]
Gavrilova, Ralitza H. [5 ]
Ghoshal, Nupur [10 ]
Graff-Radford, Neill R. [11 ]
Hsiung, Ging-Yuek Robin [12 ]
Huey, Edward D. [13 ,14 ]
Irwin, David J. [4 ]
Kantarci, Kejal [6 ]
Kaufer, Daniel I. [15 ]
Karydas, Anna M. [1 ]
Knopman, David S. [5 ]
Kornak, John [16 ]
Kramer, Joel H. [1 ]
Kukull, Walter A. [17 ]
Lapid, Maria I. [5 ]
Litvan, Irene [9 ]
Mackenzie, Ian R. A. [12 ]
Mendez, Mario F. [4 ]
Miller, Bruce L. [1 ]
Onyike, Chiadi U. [18 ]
Pantelyat, Alexander Y. [18 ]
Rademakers, Rosa [11 ]
Marisa Ramos, Eliana [4 ]
Roberson, Erik D. [19 ]
机构
[1] Univ Calif San Francisco, Dept Neurol, Weill Inst Neurosci, Memory & Aging Ctr, San Francisco, CA 94110 USA
[2] Erasmus MC, Rotterdam, Netherlands
[3] UCL, Dementia Res Ctr, London, England
[4] Univ Calif Los Angeles, Los Angeles, CA USA
[5] Mayo Clin, Rochester, MN USA
[6] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
[8] Indiana Univ, Sch Med, Indianapolis, IN USA
[9] Univ Calif San Diego, La Jolla, CA 92093 USA
[10] Washington Univ, Sch Med, St Louis, MO USA
[11] Mayo Clin, Jacksonville, FL 32224 USA
[12] Univ British Columbia, Vancouver, BC, Canada
[13] Columbia Univ, Dept Psychiat, New York, NY USA
[14] Columbia Univ, Dept Neurol, New York, NY USA
[15] Univ N Carolina, Chapel Hill, NC 27515 USA
[16] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
[17] Univ Washington, Natl Alzheimers Coordinating Ctr, Seattle, WA 98195 USA
[18] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[19] Univ Alabama Birmingham, Birmingham, AL USA
[20] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada
[21] Assoc Frontotemporal Degenerat, Radnor, PA USA
[22] Univ Southern Calif, USC Mark & Mary Stevens Neuroimaging & Informat I, Los Angeles, CA 90007 USA
[23] Northwestern Feinberg Sch Med, Chicago, IL USA
来源
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY | 2021年 / 8卷 / 01期
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
GENETIC FRONTOTEMPORAL DEMENTIA; TAU GENE; BEHAVIORAL VARIANT; EXON; 10; DISEASE; ATROPHY; TAUOPATHY; PATTERNS; C9ORF72; N279K;
D O I
10.1002/acn3.51249
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: MAPT mutations typically cause behavioral variant frontotemporal dementia with or without parkinsonism. Previous studies have shown that symptomatic MAPT mutation carriers have frontotemporal atrophy, yet studies have shown mixed results as to whether presymptomatic carriers have low gray matter volumes. To elucidate whether presymptomatic carriers have lower structural brain volumes within regions atrophied during the symptomatic phase, we studied a large cohort of MAPT mutation carriers using a voxelwise approach. Methods: We studied 22 symptomatic carriers (age 54.7 +/- 9.1, 13 female) and 43 presymptomatic carriers (age 39.2 +/- 10.4, 21 female). Symptomatic carriers' clinical syndromes included: behavioral variant frontotemporal dementia (18), an amnestic dementia syndrome (2), Parkinson's disease (1), and mild cognitive impairment (1). We performed voxel-based morphometry on T1 images and assessed brain volumetrics by clinical subgroup, age, and mutation subtype. Results: Symptomatic carriers showed gray matter atrophy in bilateral frontotemporal cortex, insula, and striatum, and white matter atrophy in bilateral corpus callosum and uncinate fasciculus. Approximately 20% of presymptomatic carriers had low gray matter volumes in bilateral hippocampus, amygdala, and lateral temporal cortex. Within these regions, low gray matter volumes emerged in a subset of presymptomatic carriers as early as their thirties. Low white matter volumes arose infrequently among presymptomatic carriers. Interpretation: A subset of presymptomatic MAPT mutation carriers showed low volumes in mesial temporal lobe, the region ubiquitously atrophied in all symptomatic carriers. With each decade of age, an increasing percentage of presymptomatic carriers showed low mesial temporal volume, suggestive of early neurodegeneration.
引用
收藏
页码:95 / 110
页数:16
相关论文
共 50 条
  • [21] Elevated 4R-tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation
    Seto-Salvia, Nuria
    Esteras, Noemi
    de Silva, Rohan
    de Pablo-Fernandez, Eduardo
    Arber, Charles
    Toomey, Christina E.
    Polke, James M.
    Morris, Huw R.
    Rohrer, Jonathan D.
    Abramov, Andrey Y.
    Patani, Rickie
    Wray, Selina
    Warner, Thomas T.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (04) : 1327 - 1331
  • [22] 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
    Smith, Ruben
    Puschmann, Andreas
    Scholl, Michael
    Ohlsson, Tomas
    van Swieten, John
    Honer, Michael
    Englund, Elisabet
    Hansson, Oskar
    BRAIN, 2016, 139 : 2372 - 2379
  • [23] Evolution from the asymptomatic to symptomatic state in familial FTD: longitudinal neuropsychological and MRI findings in three MAPT mutation carriers
    Dheel, C.
    Przybelski, S.
    Senjem, M.
    Kantarci, K.
    Jones, D.
    Fields, J.
    Machulda, M.
    Jack, C., Jr.
    Rademakers, R.
    Knopman, D.
    Wszolek, Z.
    Petersen, R.
    Boeve, B.
    JOURNAL OF NEUROCHEMISTRY, 2016, 138 : 403 - 403
  • [24] Functional Brain Imaging in Glucocerebrosidase Mutation Carriers With and Without Parkinsonism
    Kono, Satoshi
    Ouchi, Yasuomi
    Terada, Tatsuhiro
    Ida, Hiroyuki
    Suzuki, Makiko
    Miyajima, Hiroaki
    MOVEMENT DISORDERS, 2010, 25 (12) : 1823 - 1829
  • [25] Are parkin mutation carriers better candidates for deep brain stimulation?
    Lohmann, E.
    Welter, M. L.
    Fraix, V.
    Krack, P.
    Laine, S.
    Hueto, J.-L.
    Mesnage, V.
    Pollak, P.
    Durr, A.
    Brice, A.
    MOVEMENT DISORDERS, 2007, 22 : S132 - S132
  • [26] Longevity and MEFV mutations: a study in mutation carriers
    Shinar, Y.
    Golberg, M.
    Navalenia, I.
    Livneh, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (02) : 199 - 199
  • [27] In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms
    Jones, David T.
    Knopman, David S.
    Graff-Radford, Jonathan
    Syrjanen, Jeremy A.
    Senjem, Matthew L.
    Schwarz, Christopher G.
    Dheel, Christina
    Wszolek, Zbigniew
    Rademakers, Rosa
    Kantarci, Kejal
    Petersen, Ronald C.
    Jack, Clifford R., Jr.
    Lowe, Val J.
    Boeve, Bradley F.
    NEUROLOGY, 2018, 90 (11) : E947 - +
  • [28] Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort:: comparison with patients with MAPT and no known mutations
    Pickering-Brown, Stuart M.
    Rollinson, Sara
    Du Plessis, Daniel
    Morrison, Karen E.
    Varma, Anoop
    Richardson, Anna M. T.
    Neary, David
    Snowden, Julie S.
    Mann, David M. A.
    BRAIN, 2008, 131 : 721 - 731
  • [29] THE EVOLUTION OF FRONTOTEMPORAL DEMENTIA DUE TO THE MAPT MUTATION: A SEVENTEEN YEAR NATURAL HISTORY STUDY
    Mahoney, Colin
    Yeatman, T.
    Rohrer, J. D.
    Manning, E.
    Leung, K. K.
    Rossor, M. N.
    Warren, J. D.
    Fox, N.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11):
  • [30] The evolution of Frontotemporal Dementia due to the MAPT mutation: a seventeen year natural history study
    Mahoney, Colin
    Yeatman, Tom
    Rohrer, Jonathan
    Manning, Emily
    Leung, Kelvin
    Downey, Laura
    Rossor, Martin
    Warren, Jason
    Fox, Nick
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 84 - 85